IPEG Policy on Disclosing Financial Relationships with Ineligible Companies (formerly "Commercial Interests") and Managing Conflicts of Interest

IPEG must ensure balance and independence in all of its accredited educational activities.

**NEW** The ACCME expects individuals involved with CME to disclose ALL financial relationships with ineligible company in the past 24 μήνες. An ineligible company is defined by the ACCME as:

“those whose primary business is producing, εμπορία, πώληση, μεταπώληση, or distributing healthcare products used by or on patients.”

Examples of such organizations include:

• Advertising, εμπορία, or communication firms whose clients are ineligible companies
• Bio-medical startups that have begun a governmental regulatory approval process
• Compounding pharmacies that manufacture proprietary compounds
• Device manufacturers or distributors
• Diagnostic labs that sell proprietary products
• Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
• Manufacturers of health-related wearable products
• Pharmaceutical companies or distributors
• Pharmacy benefit managers
• Reagent manufacturers or sellers

The ACCME does not consider providers of clinical service directly to patients to be ineligible companies. There is no minimum threshold; we ask that you disclose all financial relationships, regardless of the amount, with ineligible companies. You no longer need to disclose for your spouse/partner.